State and local officials are reportedly in talks with three major drug distributors on a potential $18 billion settlement of litigation that blames them for helping to fuel the U.S. opioid epidemic.
The potential settlement, according to the Wall Street Journal, would require McKesson Corp., AmerisourceBergen Corp. and Cardinal Health to collectively pay the $18 billion over 18 years. Drugmaker Johnson & Johnson is also involved in the discussions to pay extra money, the WSJ reported, citing people familiar with the discussions.
This is breaking news. Please check back for updates.
This article was originally published by Cnbc.com. Read the original article here.